These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7102126

  • 1. [Current immunologic findings in bladder cancer].
    Seyfarth M, Hudemann B, Erdmann T.
    Z Urol Nephrol; 1982 Mar; 75(3):153-7. PubMed ID: 7102126
    [Abstract] [Full Text] [Related]

  • 2. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
    Flamm J, Grof F.
    Wien Med Wochenschr; 1981 Oct 31; 131(20):501-6. PubMed ID: 7314632
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C, LaRue H, Hovington H, Decobert M, Harel F, Bergeron A, Têtu B, Lacombe L, Fradet Y.
    Eur Urol; 2009 Jun 31; 55(6):1386-95. PubMed ID: 19193487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
    Sanchez-Carbayo M, Urrutia M, Romani R, Herrero M, Gonzalez de Buitrago JM, Navajo JA.
    Anticancer Res; 2001 Jun 31; 21(4B):3041-7. PubMed ID: 11712808
    [Abstract] [Full Text] [Related]

  • 11. [Immunodiagnosis and immunotherapy of bladder tumors].
    Kadagidze ZG, Shipilov VI.
    Urol Nefrol (Mosk); 1984 Jun 31; (1):69-72. PubMed ID: 6367184
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM, Ninalga C, Essand M, Loskog A, Tötterman TH.
    J Immunother; 2008 Jan 31; 31(1):34-42. PubMed ID: 18157010
    [Abstract] [Full Text] [Related]

  • 14. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
    Sharma P, Bajorin DF, Jungbluth AA, Herr H, Old LJ, Gnjatic S.
    J Immunother; 2008 Jan 31; 31(9):849-57. PubMed ID: 18833002
    [Abstract] [Full Text] [Related]

  • 15. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG, Lee SJ, Huh JS, Lee JH.
    Oncol Rep; 2001 Jan 31; 8(2):257-61. PubMed ID: 11182036
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokines.
    Videira PA, Calais FM, Correia M, Ligeiro D, Crespo HJ, Calais F, Trindade H.
    Urology; 2009 Oct 31; 74(4):944-50. PubMed ID: 19428084
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR, Noel JC, Fayt I, Drowart A, Van Vooren JP, Huygen K, Simon J, Schulman CC.
    J Urol; 1999 Mar 31; 161(3):792-8. PubMed ID: 10022686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.